BiotechTube
Home/EydisBio/Dr. Scott Scarneo, MBA, PhD
DS

Dr. Scott Scarneo, MBA, PhD

Chief Scientific Officer

EydisBio

Therapeutic Areas

Autoimmune DiseasesInflammatory DiseasesChronic PainFibrotic Diseases

EydisBio Pipeline

DrugIndicationPhase
EYD-001 (Takinib analog)Rheumatoid ArthritisPreclinical
Pipeline of small moleculesAutoimmune/Inflammatory Diseases & Immune-related CancersDiscovery

Leadership Team at EydisBio

DT
Dr. Timothy Haystead, PhD
President & Founder
DP
Dr. Philip Hughes, PhD
Executive Vice President of Chemistry
View full EydisBio profile